The intersection of sexually transmitted infections and antimicrobial stewardship: opportunities for synergy - Volume 6 Issue 1

Abstract. In our retrospective review, there were 186 patients who received a doxycycline post-exposure prophylaxis (doxy PEP) prescription with 56% missin

Some statements are wrong enough to make your head explode.

Atlanta, GA | October 19–22, 2025The infectious diseases community is gathering once again for IDWeek 2025, and the University of Nebraska Medical Center (UNMC) Division of Infectious Diseases is prou...

Abstract. Long-acting cabotegravir/rilpivirine offers a low incidence of virologic failure. However, drug resistance can develop after discontinuation with

Several representatives of the UNMC/NM Specialty Care Center attended the 20th anniversary of the Continuum Conference (formerly Adherence Conference) in San Juan, Puerto Rico. This is an annual confe...

Ensitrelvir is an antiviral agent against SARS-CoV-2 with associated drug-drug interactions (DDI) through CYP3A, P-gp, BCRP, and OAT-3 inhibition.

From opposition to advocacy: After dismissing vaccine over promiscuity fears, church now tells faithful early intervention saves lives

Treatment of hepatitis C virus (HCV) during pregnancy can cure maternal HCV and prevent perinatal HCV transmission. The primary objective was to compare the pharmacokinetics (PK) of sofosbuvir (SOF)/velpatasvir (VEL) in pregnant versus nonpregnant people.

There are patients you can never forget. Some because you connected unusually deeply with them as people or with their stories—some because you may have seen yourself or a loved one in their shoes, on...

Gepotidacin demonstrated non-inferiority to ceftriaxone plus azithromycin for urogenital N gonorrhoeae, with no new safety concerns, offering a novel oral treatment option for uncomplicated urogenital...

The industry can’t continue to sit idly by while Robert F. Kennedy Jr. guts the nation’s public health agencies.

Long-acting injectable cabotegravir/rilpivirine (LAI-CAB/RPV) may improve outcomes among persons with HIV (PWH) with adherence difficulties to oral therapy.

Rates of bacterial sexually transmitted infections (STIs) have risen dramatically over the past decades. Doxycycline postexposure prophylaxis (DP) is a novel intervention to prevent bacterial STIs. Recent randomized controlled clinical trials reported high DP efficacy at preventing syphilis and chlamydia in cisgender men who have sex with men (MSM) and transgender women.